Showing results (331-340 of 2,056) with videos related to

Sort By:
Pageof 206
Brachytherapy|June 5, 2021
Adverse events of after-loading high dose rate brachytherapy reported to the United States Food and Drug Administration (FDA)Destie Provenzano, Kevin Rao, Gizem Cifter, et al.
Brachytherapy|November 27, 2022
A "scoping" review of prostate brachytherapy and immune responsesAnthony T Nguyen, Chung-Tang Spencer Liu, Mitchell Kamrava
Brachytherapy|June 7, 2022
Gynecological intrauterine brachytherapy training for radiation therapists: The development and implementation of a training programSylvia Hanna, Carminia Lapuz, Adeline Lim
Brachytherapy|December 17, 2022
Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapyAba Anoa Scott, Madrigal Weersink, Zhihui Amy Liu, et al.
Brachytherapy|December 17, 2022
Implementing a simulation-based curriculum for hybrid intracavitary/interstitial brachytherapy using a new, commercially available, US/MR/CT-compatible gynecologic phantomJessie Y Li, Christopher J Tien, Megan Kassick, et al.
Brachytherapy|May 6, 2022
Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancerKilian E Salerno, Baris Turkbey, Liza Lindenberg, et al.
Brachytherapy|May 10, 2022
Validation of a commercial software dose calculation for Y-90 microspheresM Guerrero, W Yao, M Lin, et al.
Brachytherapy|July 7, 2021
Acute and late complications and toxicities of skin brachytherapyAmandeep S Taggar, Paveen Mann, Alexandra Stewart, et al.
Brachytherapy|June 17, 2022
The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABTJintana Ruanla, Pooriwat Muangwong, Kittikun Kittidachanan, et al.
Brachytherapy|June 17, 2022
Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongueChristopher K Cheung, Jessica Chew, Katherine Wai, et al.
Pageof 206